These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M. J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893 [Abstract] [Full Text] [Related]
25. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A. Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374 [Abstract] [Full Text] [Related]
26. Increased frequency of positive family history of dementia in sporadic CJD. Krasnianski A, von Ahsen N, Heinemann U, Meissner B, Schulz-Schaeffer WJ, Kretzschmar HA, Armstrong VW, Zerr I. Neurobiol Aging; 2009 Apr; 30(4):615-21. PubMed ID: 17822808 [Abstract] [Full Text] [Related]
28. Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio. Slemmon JR, Shapiro A, Mercken M, Streffer J, Romano G, Andreasen N, Zetterberg H, Blennow K. J Neurochem; 2015 Dec; 135(5):1049-58. PubMed ID: 26332787 [Abstract] [Full Text] [Related]
29. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H, AddNeuroMed Consortium. J Alzheimers Dis; 2010 Dec; 21(3):947-66. PubMed ID: 20693633 [Abstract] [Full Text] [Related]
30. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers. Lamsa R, Helisalmi S, Herukka SK, Tapiola T, Pirttila T, Vepsalainen S, Hiltunen M, Soininen H. Dement Geriatr Cogn Disord; 2007 Dec; 24(2):146-50. PubMed ID: 17622762 [Abstract] [Full Text] [Related]
31. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI. Herukka SK, Helisalmi S, Hallikainen M, Tervo S, Soininen H, Pirttilä T. Neurobiol Aging; 2007 Apr; 28(4):507-14. PubMed ID: 16546302 [Abstract] [Full Text] [Related]
33. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L. J Alzheimers Dis; 2010 Apr; 21(2):471-8. PubMed ID: 20555147 [Abstract] [Full Text] [Related]